Skip to main content
Clinical Trials/TCTR20201117001
TCTR20201117001Completed未知

Evaluation of Adverse Events and Health-Related Quality of Life in Patients with Colorectal Cancer Receiving Ambulatory Home-Based Chemotherapy in Thailand

Ramathibodi Hospital, Mahidol University0 sites175 target enrollmentStarted: November 17, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
175

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20 Years to 85 Years (—)
Sex
All

Inclusion Criteria

  • 1. Colorectal cancer patient
  • 2. Treatment: oxaliplatin/leucovirin/5-fluorouracil (mFOLFOX) and
  • Irinotecan/leucovirin/5-fluorouracil (FOLFIRI) with 5-fluorouracil contrnuous infusion for 48-50 hours (both regimens)
  • 3. Good ECOG performance status <3
  • 4. Good compliance
  • 5. Signed consent form

Exclusion Criteria

  • 1. Uncontrolled underlying disease
  • 2. Cognitive impairment (it might be impacted of selfcare and device care at home)

Investigators

Sponsor
Ramathibodi Hospital&#44; Mahidol University

Similar Trials